Skip to content
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Rheumatology · Undifferentiated Connective Tissue Disease

How Can You Tell UCTD Fatigue From a Flare or Other Causes?

At a Glance

Fatigue alone cannot show whether UCTD is active. Doctors compare new symptoms with blood, urine, and autoimmune test changes while checking treatable causes such as anemia, thyroid disease, poor sleep, infection, medication effects, and fibromyalgia.

Fatigue is one of the most common and disabling symptoms of Undifferentiated Connective Tissue Disease (UCTD), but it is not always caused by active autoimmune inflammation [1]. Because UCTD means your symptoms and lab results suggest a connective-tissue disease but do not meet the full criteria for conditions like lupus or systemic sclerosis, your disease course is unique [2]. While many people with UCTD remain stable, fatigue severity alone does not reliably predict whether your condition is evolving or active [1]. To tell the difference between active inflammation and other common causes—like anemia, thyroid disease, poor sleep, or fibromyalgia—doctors look at your complete clinical picture rather than relying on fatigue alone [2]. Because fatigue often does not match your laboratory measures of autoimmune activity, your care team should evaluate non-inflammatory causes before escalating your immunosuppressive medications [1] [3].

Clues That Prompt Concern for Active UCTD

There is no universally accepted “flare checklist” for UCTD, and a normal inflammatory marker test (like ESR or CRP) does not completely rule out active disease [4]. However, clinicians look for objective changes that may suggest an inflammatory flare or evolution toward a defined connective-tissue disease.
These clues include:

  • New or worsening physical symptoms: Inflammatory arthritis (swollen, hot joints), new rashes, mouth ulcers, or prolonged morning stiffness [2].
  • Changes in specific lab tests: Dropping blood cell counts (cytopenias), dropping complement levels (such as C4), the appearance of new autoantibodies (like anti-dsDNA or anti-Sm), or new urine abnormalities [5] [6]. While these findings can also have other causes (such as medication side effects or infection), their appearance warrants careful clinician assessment.

Differentiating Other Common Causes of Fatigue

When evaluating severe fatigue, your care team will also consider non-rheumatic conditions and infections that can coexist with UCTD:

  • Infections: Infections can directly cause severe fatigue and mimic an autoimmune flare, which is especially dangerous if you take immunosuppressive medications [7]. Symptoms like fever, chills, cough, or urinary changes require prompt attention, and elevated inflammatory markers (CRP/ESR) might indicate infection rather than a flare [4].
  • Anemia and Nutritional Deficiencies: Low hemoglobin or hematocrit (anemia) or deficiencies in iron or vitamin B12 can cause profound exhaustion [8] [9]. Interestingly, even iron deficiency without full-blown anemia can contribute to significant fatigue [10].
  • Thyroid Disease: Thyroid autoantibodies are prevalent in people with connective tissue diseases, making conditions like hypothyroidism (underactive thyroid) a frequent, treatable cause of fatigue [3] [11].
  • Poor Sleep and Sleep Apnea: Unrefreshing sleep, morning headaches, and excessive daytime sleepiness can point to obstructive sleep apnea rather than autoimmune activity [12]. Sleep disorders are common in people with chronic pain and require entirely different treatments than a UCTD flare [13].
  • Fibromyalgia: Fibromyalgia often coexists with autoimmune diseases; some studies indicate a significant portion of ANA-positive patients also meet fibromyalgia criteria, which drastically worsens fatigue and physical quality of life [1] [14]. Fibromyalgia features widespread pain, cognitive difficulty (“brain fog”), and nonrestorative sleep. While routine inflammatory labs are normal, a physical exam may reveal widespread tenderness (allodynia) [9] [15].
  • Medication Side Effects: Medications used to treat UCTD or other conditions can cause fatigue. For instance, specific medications (like diuretics or steroids) can cause low potassium (hypokalemia), while others can cause abnormal liver enzyme tests that prompt your doctor to adjust your dose [16] [17]. Never start, stop, or adjust your prescribed medications without consulting your clinician.
  • Mood and Deconditioning: Living with chronic illness is emotionally and physically taxing. Anxiety, depression, and physical deconditioning (loss of muscle strength from decreased activity) are genuine, treatable contributors to exhaustion that can coexist with inflammation [18].

Because UCTD is individualized, no single antibody or lab confirms a flare. Before assuming your fatigue requires a higher dose of immunosuppressants, your doctor will likely individualize testing based on your specific symptoms:

  • Complete Blood Count (CBC) and Iron Studies: To check for anemia, dropping white blood cells, or low platelets [5]. Ferritin levels may be checked for iron deficiency, though they must be interpreted carefully because ferritin can look falsely normal or high if you have active inflammation [9] [10]. Vitamin B12 levels may also be checked [8].
  • Thyroid Function (TSH): An initial screening test for an underactive or overactive thyroid, which may be followed by free T4 testing depending on the results [3].
  • Kidney Function and Electrolytes: Testing your creatinine (eGFR) and electrolytes helps check kidney health and rule out medication side effects [17]. If kidney involvement is suspected, a quantitative urine test (like a protein-to-creatinine ratio) is more precise than a standard urinalysis [2].
  • Specific Autoimmune Labs: Checking complement levels (C4) or looking for specific autoantibodies may help assess if your condition is evolving, though these tests are interpreted alongside your physical symptoms [6].

Warning Symptoms: When to Seek Immediate Care

Some symptoms accompanying fatigue warrant emergency medical evaluation because they can indicate life-threatening complications, such as a heart attack, pulmonary embolism, stroke, or severe infection (not just a UCTD flare):

  • Severe or persistent chest pain and significant breathing difficulty: Seek emergency care. These can be signs of a heart attack or blood clot, though they can also reflect inflammation of the heart or lung linings (serositis) or heart muscle (myocarditis) [19] [20].
  • Sudden weakness, speech changes, vision changes, or new focal neurologic symptoms: Seek emergency care for potential stroke or severe neurological involvement [21].
  • Severe bleeding, fainting, or high fever while on immunosuppressants: These require urgent evaluation for dangerous drops in blood cells or severe infections [22] [23].

Symptoms needing prompt (but not necessarily emergency) same-day or next-day review include:

  • Foamy urine or sudden leg swelling, which could suggest significant protein loss in the urine due to kidney involvement [24].
  • New, hot, swollen joints or sudden widespread rashes [2].

Action Plan

To help your doctor distinguish between these causes, keep a short symptom diary. Track your sleep quality, morning stiffness, joint swelling, pain levels, new rashes, and any recent medication changes to bring to your next appointment.

Common questions in this guide

Does severe fatigue by itself mean my UCTD is flaring?
No. Fatigue severity alone does not reliably show that UCTD is active or evolving, and normal ESR or CRP results do not completely rule out inflammation. Doctors look for changes such as new swollen joints, rashes, mouth ulcers, falling blood counts or complement levels, new autoantibodies, or urine abnormalities.
What tests can find non-inflammatory causes of fatigue with UCTD?
A clinician may order a complete blood count, iron studies including ferritin, vitamin B12, and thyroid tests such as TSH and, if needed, free T4. Kidney function, electrolytes, and urine tests can identify organ involvement or medication effects, while selected autoimmune tests may help assess UCTD activity. The tests should be chosen based on symptoms and interpreted together.
Can low iron, anemia, or thyroid disease cause fatigue even if UCTD is stable?
Yes. Low hemoglobin or hematocrit can cause marked exhaustion, and iron deficiency may cause fatigue even before anemia develops. An underactive thyroid is another common, treatable cause that can occur alongside connective-tissue disease.
Could sleep apnea or fibromyalgia explain my fatigue and pain?
Yes. Unrefreshing sleep, morning headaches, and excessive daytime sleepiness can suggest sleep apnea, while fibromyalgia commonly causes widespread pain, brain fog, nonrestorative sleep, and tenderness. These conditions can coexist with UCTD and usually require different evaluation and treatment.
Should I change my UCTD medicine if fatigue gets worse?
Do not start, stop, or change a prescribed medicine on your own. Fatigue can come from inflammation, infection, another medical condition, or a medication side effect, so your clinician should review your symptoms, medicines, and appropriate tests before changing immunosuppressive treatment.
When does fatigue with UCTD require emergency care?
Seek emergency care for severe or persistent chest pain, major breathing difficulty, sudden weakness, speech or vision changes, severe bleeding, or fainting. A high fever while taking immunosuppressive medicine also needs urgent evaluation because it may signal a serious infection or dangerous blood-count change.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Undifferentiated connective tissue syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific lab tests, such as a full thyroid panel, ferritin, or B12, should we run to rule out non-inflammatory causes of my fatigue?
  2. 2.Do my recent lab results show any objective signs of active inflammation or UCTD evolution, understanding that no single test confirms a flare?
  3. 3.Could any of my current medications or supplements be contributing to my exhaustion or causing side effects we should monitor?
  4. 4.Based on my symptoms, would it be beneficial to evaluate my sleep quality or screen for obstructive sleep apnea?
  5. 5.How can we determine if my fatigue and pain are related to a coexisting condition like fibromyalgia alongside or instead of UCTD activity?

References

References (24)
  1. 1

    Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.

    Hafiz W, Nori R, Bregasi A, et al.

    Arthritis research & therapy 2019; (21(1)):223 doi:10.1186/s13075-019-2013-9.

    PMID: 31685018
  2. 2

    Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease.

    Radin M, Schreiber K, Cecchi I, et al.

    Arthritis care & research 2021; (73(12)):1804-1808 doi:10.1002/acr.24391.

    PMID: 32702197
  3. 3

    The prevalence of thyroid autoantibodies in autoimmune connective tissue diseases: a systematic review and meta-analysis.

    Wang Q, Shangguan J, Zhang Y, et al.

    Expert review of clinical immunology 2020; (16(9)):923-930 doi:10.1080/1744666X.2020.1811089.

    PMID: 32811198
  4. 4

    From antinuclear antibody testing to undifferentiated connective tissue disease diagnosis: a three-year median follow-up of 119 patients.

    Yarkan Tuğsal H, Sezer S, Türker O, et al.

    Postgraduate medicine 2025; 1-11 doi:10.1080/00325481.2025.2602233.

    PMID: 41378885
  5. 5

    Undifferentiated connective tissue disease: predictors of evolution into definite disease.

    García-González M, Rodríguez-Lozano B, Bustabad S, Ferraz-Amaro I

    Clinical and experimental rheumatology 2017; (35(5)):739-745.

    PMID: 28770704
  6. 6

    Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study.

    Ciancarella C, Ceccarelli F, Picciariello L, et al.

    Clinical and experimental medicine 2025; (25(1)):134 doi:10.1007/s10238-025-01668-1.

    PMID: 40310587
  7. 7

    Tracking the Path of Migratory Pain: Unveiling Whipple Disease.

    Beirão T, Gomes L, Silva C, et al.

    Cureus 2025; (17(9)):e91494 doi:10.7759/cureus.91494.

    PMID: 41049927
  8. 8

    Co-existence of autoimmune polyglandular syndrome type 3b and undifferentiated connective tissue disease with subacute combined degeneration of spinal cord in children: a case report and literature review.

    Lang C, Huang P, Gao J, et al.

    BMC pediatrics 2024; (24(1)):817 doi:10.1186/s12887-024-05262-4.

    PMID: 39695483
  9. 9

    Management of fibromyalgia: practical guides from recent evidence-based guidelines.

    Häuser W, Ablin J, Perrot S, Fitzcharles MA

    Polish archives of internal medicine 2017; (127(1)):47-56 doi:10.20452/pamw.3877.

    PMID: 28075425
  10. 10

    Association of ferritin levels with depression, anxiety, sleep quality, and physical functioning in patients with fibromyalgia syndrome: a cross-sectional study.

    Okan S, Caglıyan Turk A, Sıvgın H, et al.

    Croatian medical journal 2019; (60(6)):515-520.

    PMID: 31894917
  11. 11

    "Three in One" - Polyautoimmunity with Multiple Autoimmune Syndrome.

    Agarwal A, Sanghi A, Agarwal M, Agarwal M

    The Journal of the Association of Physicians of India 2018; (66(1)):95-7.

    PMID: 30341853
  12. 12

    Is There a Link Between Obstructive Sleep Apnea Syndrome and Fibromyalgia Syndrome?

    Köseoğlu Hİ, İnanır A, Kanbay A, et al.

    Turkish thoracic journal 2017; (18(2)):40-46 doi:10.5152/TurkThoracJ.2017.16036.

    PMID: 29404158
  13. 13

    Comparison of sleep structure and psychometric profiles in patients with fibromyalgia, osteoarthritis and healthy controls.

    Yeung WK, Morgan K, Mckenna F

    Journal of sleep research 2018; (27(2)):290-298 doi:10.1111/jsr.12588.

    PMID: 28799194
  14. 14

    Longitudinal analysis of quality of life in patients with undifferentiated connective tissue diseases.

    Iudici M, Irace R, Riccardi A, et al.

    Patient related outcome measures 2017; (8()):7-13 doi:10.2147/PROM.S117767.

    PMID: 28203114
  15. 15

    What you can do for your fibromyalgia patient.

    Gota CE

    Cleveland Clinic journal of medicine 2018; (85(5)):367-376 doi:10.3949/ccjm.85gr.18002.

    PMID: 29733785
  16. 16

    Severe Hepatitis in a Patient With Undifferentiated Connective Tissue Disease: Diagnostic Uncertainty Between Methotrexate Toxicity and Autoimmune Liver Involvement.

    Reyad B

    Cureus 2025; (17(11)):e97526 doi:10.7759/cureus.97526.

    PMID: 41446487
  17. 17

    Refractory hypokalemia and metabolic acidosis induced by undifferentiated connective tissue disease secondary to immune checkpoint inhibitors: a case report and literature review.

    Gu Y, Yi L, Zou X, et al.

    Frontiers in oncology 2024; (14()):1442605 doi:10.3389/fonc.2024.1442605.

    PMID: 39659778
  18. 18

    [Features of fibromyalgia in patients with rheumatoid arthritis].

    Melikova NA, Filatova EG, Filatova ES

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2024; (124(2)):28-36 doi:10.17116/jnevro202412402128.

    PMID: 38465808
  19. 19

    A Case Report: Unveiling the Underlying Cause of Recurrent Pericarditis in a Patient With Undifferentiated Connective Tissue Disease.

    Boever S, Bannis K

    Cureus 2024; (16(2)):e54113 doi:10.7759/cureus.54113.

    PMID: 38487125
  20. 20

    Diplopia as the herald of fulminant myocarditis in undifferentiated connective tissue disease: a case report.

    Chen Y, Li Y, Zhang R, et al.

    Frontiers in cardiovascular medicine 2026; (13()):1848981 doi:10.3389/fcvm.2026.1848981.

    PMID: 42325674
  21. 21

    Intracranial lesion as onset symptom in a patient with early undifferentiated connective tissue disease: a case report.

    Du Y, Li C, Zhao DD, et al.

    BMC neurology 2017; (17(1)):85 doi:10.1186/s12883-017-0868-4.

    PMID: 28476103
  22. 22

    Recurrent severe thrombocytopenia induced by anti-HER2 therapy in a breast cancer patient with an underlying immune disorder: a case report and literature review.

    Wang B, Chen L, Tang Q

    Frontiers in oncology 2026; (16()):1795252 doi:10.3389/fonc.2026.1795252.

    PMID: 41883959
  23. 23

    Kingella kingae Intrauterine Infection: An Unusual Cause of Chorioamnionitis and Miscarriage in a Patient with Undifferentiated Connective Tissue Disease.

    Bonasoni MP, Palicelli A, Dalla Dea G, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020243.

    PMID: 33557386
  24. 24

    Exostosin 1/exostosin 2-associated membranous nephropathy in undifferentiated connective tissue disease: a case report and literature review.

    Ye H, Jiang X, Wu B, et al.

    BMC nephrology 2025; (26(1)):665 doi:10.1186/s12882-025-04596-0.

    PMID: 41291566

This page is for informational purposes only and does not constitute medical advice. Your clinician should evaluate your fatigue and guide testing or medication changes; seek emergency care for severe warning symptoms.